Fig. 3From: A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapyIncidence rate of time to ≥ grade 2 of radiation dermatitis between two groupsBack to article page